Insider · CIK 0001595117
Simeon George
Files at CRSP (CRISPR Therapeutics AG), NKTX (Nkarta, Inc.), ADRX (ADARx Pharmaceuticals, Inc.), DSGN (Design Therapeutics, Inc.). First filing Jul 17, 2025, latest Sep 29, 2026.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
ADRX: ADARx Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
CRSP: CRISPR Therapeutics AG
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | ADARx Pharmaceuticals, Inc. | $27M 1,600,000 shares | +32% | - | |
| 50Moderate | CRSPbuy CRISPR Therapeutics AG | $51M 989,812 shares | +1567% | +76% from low-8% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 2 | +3,334,938 | - | - | 3,334,938 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 2 | +1,113,666 | - | - | 4,448,604 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 2 | +512,897 | - | - | 4,961,501 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: See Note 2 | +592,593 | $17.00 | $10M | 5,554,094 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 3 | +1,538,691 | - | - | 1,538,691 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: See Note 3 | +414,814 | $17.00 | $7.1M | 1,953,505 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 4 | +1,667,468 | - | - | 1,667,468 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 4 | +169,001 | - | - | 1,836,469 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: See Note 5 | +592,593 | $17.00 | $10M | 592,593 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series B Preferred Stockderivativeindirect: See Note 2 | -3,907,547 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series B-1 Preferred Stockderivativeindirect: See Note 2 | -1,304,883 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series C Preferred Stockderivativeindirect: See Note 2 | -600,962 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series C Preferred Stockderivativeindirect: See Note 3 | -1,802,885 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series B Preferred Stockderivativeindirect: See Note 4 | -1,953,773 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series B-1 Preferred Stockderivativeindirect: See Note 4 | -198,019 | $0.00 | $0 | 0 | 13 d ago |
| Jul 16, 2025 | CRSP CRISPR Therapeutics AG | POpen-market purchase Common Sharesindirect: See Note 1 | +6,510 | $52.03 | $339k | 69,687 | Jul 17, 2025 |
| Jul 16, 2025 | CRSP CRISPR Therapeutics AG | POpen-market purchase Common Sharesindirect: See Note 2 | +22,319 | $52.03 | $1.2M | 238,897 | Jul 17, 2025 |
| Jul 16, 2025 | CRSP CRISPR Therapeutics AG | POpen-market purchase Common Sharesindirect: See Note 3 | +960,983 | $52.03 | $50M | 1,730,179 | Jul 17, 2025 |
| Jun 10, 2025 | DSGN Design Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 5, 2025 | NKTX Nkarta, Inc. | AGrant or award Stock Option (right to buy)derivative | +46,000 | $0.00 | $0 | 46,000 | Jun 9, 2025 |
| Jun 5, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.